XTX Topco’s Sanofi SNY Stock Holding History

XTX Topco’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,371	Closed	-$357K	–	1639
2022 Q4	$357K	Buy	+7,371	New	+$324K	0.08%	470
2022 Q3	–	Sell	-13,195	Closed	-$660K	–	1360
2022 Q2	$660K	Buy	13,195 +7,593	+136%	+$403K	0.27%	76
2022 Q1	$288K	Buy	5,602 +689	+14%	+$35.6K	0.13%	284
2021 Q4	$246K	Sell	4,913 -296	-6%	-$14.6K	0.14%	284
2021 Q3	$251K	Buy	+5,209	New	+$265K	0.08%	407

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

XTX Topco's SNY Position: Q1 2023 in Review

XTX Topco sold out of Sanofi (SNY) in Q1 2023, closing a stake of 7,371 shares — an estimated $357K sold.

XTX Topco first reported a position in SNY in Q3 2021 and held it in 5 quarters. The position peaked at $660K in Q2 2022. 678 funds tracked by Wall St. Rank hold SNY as of Q1 2023.

XTX Topco reported no remaining Sanofi position as of Q1 2023 after selling out during the quarter.
XTX Topco sold 7,371 Sanofi shares in Q1 2023, an estimated $357K.
XTX Topco first reported a position in Sanofi in Q3 2021 and held it in 5 quarters.
XTX Topco's Sanofi position peaked at $660K in Q2 2022.
678 funds tracked by Wall St. Rank held Sanofi as of Q1 2023.

Based on XTX Topco's 13F filing for Q1 2023, filed 12 May 2023.